Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States. The company develops zipalertinib, a bioavailable small molecule in Phase 3 trial for the treatment of patients with non-small cell lung cancer; CLN-978, a T cell engager to treat systemic lupus erythematosus and rheumatoid arthritis; and CLN-619, a monoclonal antibody in Phase 1 trial for the treatment of solid tumors and multiple myeloma. Its development products also include CLN-049, a humanized bispecific antibody in Phase 1 trial for the treatment of acute myeloid leukemia (AML) or myelodysplastic syndrome, as well as measurable residual disease positive AML; and CLN-617, a fusion protein in Phase 1 trial for the treatment of solid tumors. It has a collaboration agreement with Adimab, LLC to discover and/or optimize antibodies; and co-development agreement with Taiho Pharmaceutical Co., Ltd to develop zipalertinib. The company was formerly known as Cullinan Oncology, Inc. and changed its name to Cullinan Therapeutics, Inc. in April 2024. Cullinan Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Cullinan Therapeutics Inc.

In a report released today, Richard Nguyen from Bernstein reiterated a Buy rating on Capgemini SE, with a price target of €208.00. According to Tip...

Bernstein Reaffirms Their Buy Rating on Capgemini SE (0HAZ)

Jefferies analyst Charles Brennan maintained a Hold rating on Capgemini SE on June 26 and set a price target of €95.00. The company’s shares closed...

Capgemini SE (0HAZ) Receives a Hold from Jefferies

H.C. Wainwright analyst Robert Burns reiterated a Buy rating on Cullinan Management today and set a price target of $30.00. Burns covers the Health...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CGEM	$17.65	-0.23%	292.98K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CGEM	$17.65	-0.2%	292.98K
3
4
5
6

CGEM

CGEM

Get Cullinan Therapeutics Inc. Data in Excel

Get Cullinan Therapeutics Inc. Data in Excel